N2OFF, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NITO research report →
Companywww.n2off.htmline.com
N2OFF, Inc. , an agri-food tech company, develops and sells eco-friendly green treatments for the food industry to enhance food safety and shelf life of fresh produce. The company's products are based on proprietary blend of food acids combined with oxidizing agent-based sanitizers for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay.
- CEO
- David Palach
- IPO
- 2010
- Employees
- 3
- HQ
- Hod HaSharon, IL
Price Chart
Valuation
- Market Cap
- $4.22M
- P/E
- -263.97
- P/S
- -63.90
- P/B
- 209.01
- EV/EBITDA
- -0.08
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 266.67%
- Op Margin
- 10362.12%
- Net Margin
- 15562.12%
- ROE
- -94.06%
- ROIC
- -45.33%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-4,004,000 · 22.90%
- EPS
- $-3.54 · 88.64%
- Op Income
- $-5,029,000
- FCF YoY
- -11.38%
Performance & Tape
- 52W High
- $29.40
- 52W Low
- $0.57
- 50D MA
- $1.49
- 200D MA
- $5.36
- Beta
- 1.64
- Avg Volume
- 936.85K
Get TickerSpark's AI analysis on NITO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 9, 26 | Zakai Shlomo | other | 50,000 |
| Feb 9, 26 | Barda Lital | other | 50,000 |
| Feb 9, 26 | Weiss Amitay | other | 116,286 |
| Feb 9, 26 | Palach David | other | 100,000 |
| Oct 20, 25 | Silberman Alon | other | 0 |
| Oct 20, 25 | Silberman Alon | other | 146,493 |
| Oct 20, 25 | SciSparc Ltd. | other | 0 |
| May 12, 25 | Barda Lital | other | 300,000 |
| May 12, 25 | Palach David | other | 600,000 |
| Dec 23, 24 | Rosenbloom Ronen | buy | 50,000 |
Our NITO Coverage
We haven't published any research on NITO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NITO Report →